Fri, January 3, 2020
Thu, January 2, 2020
Tue, December 31, 2019
Mon, December 30, 2019
Fri, December 27, 2019
Thu, December 26, 2019
Tue, December 24, 2019
Mon, December 23, 2019
Fri, December 20, 2019

Charles Duncan Reiterated (AXSM) at Buy with Increased Target to $125 on, Dec 30th, 2019

Charles Duncan of Cantor Fitzgerald, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $104 to $125 on, Dec 30th, 2019.

Charles has made no other calls on AXSM in the last 4 months.



There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.



This is the rating of the analyst that currently disagrees with Charles


  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $158 on, Monday, December 16th, 2019